Anne Brody Rubin
Presidente en Perceive Biotherapeutics, Inc. .
Perfil
Anne Brody Rubin is currently the President at Perceive Biotherapeutics, Inc. She previously worked as the Director of Program Management at Medtronic, Inc., Director of US Marketing & Marketing Operations at Medtronic Monitoring, Inc., and as a Consultant at ForSight VISION4, Inc. From 2011 to 2016, she served as the Vice President of Marketing at ForSight VISION5, Inc. Ms. Rubin holds an MBA from Stanford Graduate School of Business and an undergraduate degree from Harvard College.
Cargos activos de Anne Brody Rubin
| Empresas | Cargo | Inicio |
|---|---|---|
Perceive Biotherapeutics, Inc.
 Perceive Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020. | Presidente | 01/01/2020 |
Antiguos cargos conocidos de Anne Brody Rubin.
| Empresas | Cargo | Fin |
|---|---|---|
ForSight VISION5, Inc.
 ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Ventas & Marketing | 01/09/2016 |
ForSight VISION4, Inc.
 ForSight VISION4, Inc. Pharmaceuticals: MajorHealth Technology ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Medtronic Monitoring, Inc.
 Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Ventas & Marketing | - |
Formación de Anne Brody Rubin.
| Harvard College | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
ForSight VISION5, Inc.
ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Electronic Technology |
Medtronic Monitoring, Inc.
Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Health Services |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
ForSight VISION4, Inc.
ForSight VISION4, Inc. Pharmaceuticals: MajorHealth Technology ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA. | Health Technology |
Perceive Biotherapeutics, Inc.
Perceive Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020. | Health Technology |
- Bolsa de valores
- Insiders
- Anne Brody Rubin
